Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study
Vaccines · 28.09.2024 · 12 (10) · 1113
DOI: 10.3390/vaccines12101113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 28.09.2024. Verfasst von Elisa Barbieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Women's and Children's Health, University of Padua, 35100 Padua, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of the Education, University and Research, European Union - Next Generation EU under the National Recovery and Resilience Plan (NRRP), European Union—Next Generation EU under the National Recovery and Resilience Plan (NRRP).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background/Objectives: Seasonal influenza annually puts a significant burden on the pediatric population, especially the youngest, causing severe illness and death. Additionally, associated healthcare costs cause a significant financial strain on healthcare systems. While vaccination is the most effective prevention method, its cost-effectiveness for healthy children remains unassessed.
Methods
Using the Pedianet database spanning from 2009 to 2019, we analyzed influenza cases among 6-month-olds to 14-year-olds in Italy. Data included influenza-related medical visits, prescriptions, exams, emergency visits, hospitalizations, and costs. Adverse events and quality-adjusted life years (QALYs) were considered from the existing literature. A static decision-tree model compared annual vaccination strategies, assessing probabilities for influenza or influenza-like illnesses by vaccination status. Incremental cost-effectiveness ratios (ICERs) were calculated, along with sensitivity analyses and cost-effectiveness acceptability curve generation.
Results
Mean total influenza costs for vaccinated children averaged EUR 18.6 (range 0–3175.9, including EUR 15.79 for the influenza vaccination), whereas costs for unvaccinated children were consistently lower at around EUR 4.6 (range 0–3250.1). The average ICER for years where vaccine and virus strains are matched was EUR 29,831 per QALY, which is below the EUR 40,000 threshold set by the Italian National Health Services. The ICER values range from EUR 13,736 (2017/2018) to EUR 72,153 (2013/2014). Averted influenza costs averaged EUR 23 per case, with fluctuations over the years. In most observed years, influenza vaccination was cost-effective from the healthcare providers’ standpoint. The exception was 2009–2010, due to a mismatch between vaccine and virus strains.
Conclusions
This study highlights the economic viability of influenza vaccination, especially when virus and vaccine strains align. It demonstrates the potential of vaccination programs in preserving children’s health and well-being while managing healthcare costs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, Department of Women's and Children's Health, University of Padua, 35100 Padua, Italy.
- Centre for Research on Health and Social Care Management, Bocconi University, 20136 Milan, Italy.
- Institut National D'études Démographiques, 75980 Paris, France.
- Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.
- National Centre for Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.
- Società Servizi Telematici-Pedianet, 35100 Padua, Italy.
ORCID-Profile: Elisa Barbieri, Yuxi Wang, Anna Cantarutti, Antonio Scamarcia, Giovanni Corrao
Förderung
- Italian Ministry of the Education, University and Research
- European Union - Next Generation EU under the National Recovery and Resilience Plan (NRRP)
- European Union—Next Generation EU under the National Recovery and Resilience Plan (NRRP)
Zitieren
APA
Barbieri, E., Wang, Y., Cantarutti, A., Scamarcia, A., Cantarutti, L., Corrao, G., Torbica, A., & Giaquinto, C. (2024). Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study. Vaccines, 12(10), 1113. https://doi.org/10.3390/vaccines12101113
Vancouver
Barbieri E, Wang Y, Cantarutti A, Scamarcia A, Cantarutti L, Corrao G, et al. Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study. Vaccines. 2024;12(10):1113. doi:10.3390/vaccines12101113
BibTeX
@article{Barbieri2024,
author = {Barbieri, Elisa and Wang, Yuxi and Cantarutti, Anna and Scamarcia, Antonio and Cantarutti, Luigi and Corrao, Giovanni and Torbica, Aleksandra and Giaquinto, Carlo},
title = {Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {10},
pages = {1113},
doi = {10.3390/vaccines12101113}
}
EUVIMED